The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy
BioFactors · 2026-01 · 52 (1)
DOI: 10.1002/biof.70072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioFactors, online erschienen am 05.01.2026. Verfasst von Mrinal K Ghosh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TR…. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Neoplasms, Cell Nucleus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 211 Literaturangaben. Gefördert von: CSIR-Indian Institute of Chemical Biology.
Abstract (Originalsprache)
Tumor suppressor Phosphatase and Tensin Homolog Deleted on Chromosome TEN (PTEN) shows a differential sub‐cellular distribution, with its nuclear presence being particularly critical for its multifaceted tumor‐suppressive functions. Nuclear PTEN mediates its arsenal of tumor suppressive actions viz., genomic stability maintenance, cell cycle regulation, DNA damage response, and transcriptional modulation, in both phosphatase‐dependent and non‐phosphatase‐dependent manners. Diverse mechanisms exist to facilitate its nuclear import, including passive diffusion, active transport, and post‐translational modifications such as monoubiquitination, phosphorylation, and SUMOylation as well as their crosstalk. Similarly, a number of mechanisms dictate the nuclear export of PTEN. Nucleo‐cytoplasmic shuttling of PTEN is closely guarded by several protein factors. This review comprehensively explores the proteins involved in the transport and regulation of nuclear PTEN. Furthermore, it highlights the clinical significance of nuclear PTEN levels, which are closely associated with tumor grade, disease prognosis, and patient survival across multiple cancer types. By elucidating these mechanisms, this review underscores the importance of nuclear PTEN in cancer biology and its potential as a therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, Kolkata, India.
- Department of Microbiology, Dhruba Chand Halder College, Nurulpur, India.
ORCID-Profile: Mrinal K Ghosh, Subhajit Karmakar
Förderung
- CSIR-Indian Institute of Chemical Biology
Zitieren
APA
Ghosh, M. K., Chakraborty, S., Karmakar, S., & Basu, M. (2026). The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy. BioFactors, 52(1). https://doi.org/10.1002/biof.70072
Vancouver
Ghosh MK, Chakraborty S, Karmakar S, Basu M. The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy. BioFactors. 2026;52(1). doi:10.1002/biof.70072
BibTeX
@article{Ghosh2026,
author = {Ghosh, Mrinal K and Chakraborty, Shrabastee and Karmakar, Subhajit and Basu, Malini},
title = {The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {1},
doi = {10.1002/biof.70072}
}
EUVIMED